Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Nature Medicine

Volumn 10, Issue 4, 2004, Pages 416-421

  Björkbacka, Harry ^a   Kunjathoor, V Vidya ^a   Moore, Kathryn J ^a   Koehn, Stephanie ^a   Ordija, Christine M ^a   Lee, Melinda A ^a   Means, Terry ^a   Halmen, Kristen ^b   Luster, Andrew D ^a   Golenbock, Douglas T ^b   Freeman, Mason W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; CHOLESTEROL; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18 RECEPTOR; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EXPERIMENTAL MOUSE; FEMALE; HYPERLIPIDEMIA; IMMUNITY; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ARTERIOSCLEROSIS; CHOLESTEROL; IMMUNITY, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 3242728901     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1008     Document Type: Article

References (33)

1. Lusis, A.J. Atherosclerosis. Nature 407, 233-241 (2000).
2. Ismail, A., Khosravi, H. & Olson, H. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis. 1, 233-240 (1999).
3. Epstein, S.E. et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler. Thromb. Vasc. Biol. 20, 1417-1420 (2000).
4. Frishman, W.H. & Ismail, A.A. Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target? Cardiol. Rev. 10, 199-210 (2002).
5. Ross, R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126 (1999).
6. Binder, C.J. et al. Innate and acquired immunity in atherogenesis. Nat. Med. 8, 1218-26 (2002).
7. Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J. & Gusovsky, F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274, 10689-10692 (1999).
8. Xu, X.H. et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104, 3103-3108 (2001).
9. Vink, A. et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation 106, 1985-1990 (2002).
10. Kiechl, S. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347, 185-192 (2002).
11. Edfeldt, K., Swedenborg, J., Hansson, G.K. & Yan, Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158-1161 (2002).
12. Wright, S.D. et al. Infectious agents are not necessary for murine atherogenesis. J. Exp. Med. 191, 1437-1442 (2000).
13. Tanaka, E. et al. Disparity of MCP-1 mRNA and protein expressions between the carotid artery and the aorta in WHHL rabbits: one aspect involved in the regional difference in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 244-250 (2003).
14. Mach, F. The role of chemokines in atherosclerosis. Curr. Atheroscler. Rep. 3, 243-251 (2001).
15. Burke-Gaffney, A., Brooks, A.V. & Bogle, R.G. Regulation of chemokine expression in atherosclerosis. Vascul. Pharmacol. 38, 283-292 (2002).
16. Gosling, J. et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103, 773-778 (1999).
17. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394, 894-897 (1998).
18. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150 (1998).
19. Kirii, H. et al. Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 656-660 (2003).
20. Elhage, R. et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc. Res. 59, 234-240 (2003).
21. Bulut, Y. et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168, 1435-1440 (2002).
22. Walton, K.A. et al. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 278, 29661-29666 (2003).
23. Raschi, E. et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101, 3495-3500 (2003).
24. Kanters, E. et al. Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112, 1176-1185 (2003).
25. Pahl, H.L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18, 6853-6866 (1999).
26. Lawrence, T., Gilroy, D.W., Colville-Nash, P.R. & Willoughby, D.A. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7, 1291-1297 (2001).
27. Moore, K.J. et al. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J. Immunol. 165, 4272-4280 (2000).
28. Kunjathoor, V.V., Wilson, D.L. & LeBoeuf, R.C. Increased atherosclerosis in streptozotocin-induced diabetic mice. J. Clin. Invest. 97, 1767-1773 (1996).
29. Kunjathoor, V.V., Chiu, D.S., O'Brien, K.D. & LeBoeuf, R.C. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22, 462-468 (2002).
30. Tangirala, R.K., Rubin, E.M. & Palinski, W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36, 2320-2328 (1995).
31. Saal, L.H. et al. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol. 3, SOFTWARE0003 (2002).
32. Moore, K.J., Naito, T., Martin, C. & Kelley, V.R. Enhanced response of macrophages to CSF-1 in autoimmune mice: a gene transfer strategy. J. Immunol. 157, 433-440 (1996).
33. Kunjathoor, V.V. et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277, 49982-49988 (2002).